Overview

Financials

News Ideas Discussions Technicals Forecast Seasonals Options

GMED fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

‪7.95 B‬USD

—

44.05

1.36USD

2003

‪5.3 K‬

Daniel T. Scavilla

globusmedical.com

About

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Ownership

‪‪112.95 M‬‬

Free Float shares

‪‪112.16 M‬‬ (99.3%)

Closely held shares

‪‪792.90 K‬‬ (0.7%)

Free Float shares

‪‪112.16 M‬‬ (99.3%)

Closely held shares

‪‪792.90 K‬‬ (0.7%)

Capital structure

Market cap

‪‪7.95 B‬‬

Debt

‪‪92.79 M‬‬

Cash & equivalents

‪‪461.27 M‬‬

Enterprise value

‪‪7.59 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary

‪‪7.95 B‬‬

Price to earning ratio (P/E)

44.05x

Price to sales ratio (P/S)

3.29x

Market Cap

Net income

Revenue

Price to earning ratio (P/E)

44.05x

Price to sales ratio (P/S)

3.29x

Valuation ratios

‪0.00‬

‪1.20‬

‪2.40‬

‪3.60‬

‪4.80‬

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪0.00‬

‪60.00‬

‪120.00‬

‪180.00‬

‪240.00‬

P/E

P/S

Growth and Profitability

Company’s recent performance and margins

Performance

‪−4.5%‬

‪0.0%‬

‪4.5%‬

‪9.0%‬

‪13.5%‬

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪‪−250.00 M‬‬

‪0.00‬

‪‪250.00 M‬‬

‪‪500.00 M‬‬

‪‪750.00 M‬‬

Revenue

Net income

Net margin %

Revenue to profit conversion

Revenue

COGS

Gross profit

Op expenses

Op income

Non-Op income/ expenses

Taxes & Other

Net income

‪0.00‬

‪‪150.00 M‬‬

‪‪300.00 M‬‬

‪‪450.00 M‬‬

‪‪600.00 M‬‬

Revenue

COGS

Gross profit

Expenses & adjustments

Net income

‪0.00‬

‪‪150.00 M‬‬

‪‪300.00 M‬‬

‪‪450.00 M‬‬

‪‪600.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business

Period: 2024

Musculoskeletal Solutions

Enabling Technologies

By country

Period: 2024

United States

International

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪0.00‬

‪‪200.00 M‬‬

‪‪400.00 M‬‬

‪‪600.00 M‬‬

‪‪800.00 M‬‬

Actual

Estimate

Earnings

Next:Jul 31, 2025

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪0.00‬

‪0.21‬

‪0.42‬

‪0.63‬

‪0.84‬

Actual

Estimate

Dividends

Dividend yield, history and sustainability

No dividends

GMED has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

‪0.00‬

‪‪200.00 M‬‬

‪‪400.00 M‬‬

‪‪600.00 M‬‬

‪‪800.00 M‬‬

Debt

Free cash flow

Cash & equivalents

Financial position analysis

Short term

Long term

‪0.00‬

‪‪800.00 M‬‬

‪‪1.60 B‬‬

‪‪2.40 B‬‬

‪‪3.20 B‬‬

Assets

Liabilities